PIK3CA mutations in gallbladder cancers

被引：0
|
作者：
Shigematsu, Hisayuki
Takahashi, Takao
Minna, John D.
Gazdar, Adi F.
Wistuba, Ignacio I.
机构：
[1] Okayama Univ, Okayama, Japan
[2] UT Southwestern Med Ctr, Dallas, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
214
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Mutations in PIK3CA are infrequent in neuroblastoma
    Dam, Vincent
    Morgan, Brian T.
    Mazanek, Pavel
    Hogarty, Michael D.
    BMC CANCER, 2006, 6 (1)
  • [22] PIK3CA mutations in vascular malformations
    Castillo, Sandra D.
    Baselga, Eulalia
    Graupera, Mariona
    CURRENT OPINION IN HEMATOLOGY, 2019, 26 (03) : 170 - 178
  • [23] PIK3CA mutations in oligodendroglial tumours
    Hartmann, C
    Devermann, L
    Gehlhaar, C
    Holtkamp, N
    von Deimling, A
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2006, 32 (02) : 209 - 212
  • [24] PIK3Ca mutations in prostate cancer
    Agell, Laia
    Hernandez, Silvia
    de Muga, Silvia
    Lorente, Jose Antonio
    Juanpere, Nuria
    Esgueva, Raquel
    Gelabert, Antoni
    Serrano, Sergi
    Lloreta, Josep
    VIRCHOWS ARCHIV, 2008, 452 : S26 - S27
  • [25] PIK3CA mutations in glioblastoma multiforme
    Hartmann, C
    Bartels, G
    Gehlhaar, C
    Holtkamp, N
    von Deimling, A
    ACTA NEUROPATHOLOGICA, 2005, 109 (06) : 639 - 642
  • [26] PIK3CA mutations in nasopharyngeal carcinoma
    Or, YYY
    Hui, ABY
    To, KF
    Lam, CNY
    Lo, KW
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (04) : 1065 - 1067
  • [27] Inavolisib in cancers with activating PIK3CA mutations: Results from the CRAFT trial
    Heilig, C. E.
    Teleanu, M-V.
    Desuki, A.
    Kindler, T.
    Deschler, B.
    Kunzmann, V.
    von Bubnoff, N.
    Illert, L.
    Rieke, D. T.
    Suesse, H.
    Heiligenthal, L.
    Kreutzfeldt, S.
    Horak, P.
    Steindorf, K.
    Benner, A.
    Huebschmann, D.
    Schweigert, N.
    Glimm, H.
    Froehling, S.
    Schlenk, R. F.
    ANNALS OF ONCOLOGY, 2024, 35 : S295 - S296
  • [28] Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population
    J Abubaker
    P Bavi
    S Al-Harbi
    M Ibrahim
    A K Siraj
    N Al-Sanea
    A Abduljabbar
    L H Ashari
    S Alhomoud
    F Al-Dayel
    S Uddin
    K S Al-Kuraya
    Oncogene, 2008, 27 : 3539 - 3545
  • [29] PIK3CA mutations in patients with advanced cancers treated in a phase I clinic
    Janku, F.
    Hong, D. S.
    Tsimberidou, A. M.
    Naing, A.
    Falchook, G. S.
    Wheler, J. J.
    Moulder, S. L.
    Kurzrock, R.
    EJC SUPPLEMENTS, 2009, 7 (04): : 20 - 20
  • [30] Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population
    Abubaker, Jehad
    Bavi, Prashant
    Al-Harbi, Sayer
    Ibrahim, Muna
    Ai-Sanea, Nasser
    Jabbar, Alaa Abdul
    Ashari, Luai
    Alhomoud, Samar
    Al-Dayel, Fouad
    Uddin, Shahab
    Al-Kuraya, Khawla
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3486S - 3487S
12345